ALIQOPA
国家: 以色列
语言: 英文
来源: Ministry of Health
该产品的某些文档当前不可用，您可以向我们的客户服务发送请求，我们将在获得它们后尽快通知您。
发送请求。
发送请求。
有效成分:
COPANLISIB AS DIHYDROCHLORIDE
可用日期:
BAYER ISRAEL LTD
ATC代码:
L01XX61
药物剂型:
POWDER FOR CONCENTRATED SOLUTION FOR INFUSION
组成:
COPANLISIB AS DIHYDROCHLORIDE 60 MG/VIAL
给药途径:
I.V
处方类型:
Required
厂商:
BAYER AG, GERMANY
治疗领域:
COPANLISIB
疗效迹象:
Aliqopa is indicated for the treatment of adult patients with relapsed follicular lymphoma (FL) who have received at least two prior systemic therapies.
授权日期:
2020-10-01
